Sign in:
Email
 Password  save:
  
 Company Reports 
 

   
My Recent Searches
  Help
 
   
 
 
   Get Roster for :  
Cymabay Therapeutics, Inc. (CBAY)  
$32.48 0.00 (0.00%) as of 4:30 Thu 3/21


Download
   
  Company Roster

Total Insiders  : 24  
Total Direct Shares :
2,257,866
Total Indirect Shares :
13,100,977
 
% Held by Insiders:
1.97%
 
5 other people own 
 $1,150,636 Von Emster Kurt
 $2,923,200 Stein Evan A.
 $4,933,062 Alta Embarcadero Biopharm...
 $31,194,864 Versant Side Fund Ii, Lp
 $33,133,725  
 
Filer's Name Relation Direct Date   Direct Shares Indirect Date Indirect Shares
   Shantharam Harish 2024-03-22 0 2024-01-24 0
   Wills Robert James 2024-03-22 0 2016-09-06 0
   Shah Sujal 2024-03-22 0 2014-09-16 0
   Quinlan Paul T 2024-03-22 0 2023-05-15 0
   Dickinson Klara 2024-03-22 0 2024-01-24 0
   Emster Kurt Von 2024-03-22 0 2023-09-29 18,406
   Mcwherter Charles 2024-03-22 0 2015-05-15 0
   Dorling Janet Director 2024-02-12 0 2023-11-10 0
   Menold Daniel Vice President, Finance 2024-01-16 0 2018-08-29 0
   Kim Dennis D Chief Medical Officer 2023-04-17 20,000 2022-01-19 0
   Stuart Lewis J Officer 2021-05-10 1,000 0
   Goldfischer Carl Director 2019-02-07 0 2015-09-11 0
   Omara Patrick J. VP, Business Development 2016-04-15 5,022 0
   Stein Evan A. Director 2016-04-01 151,880 0
   Von Emster Kurt Director 2015-08-14 90,000 2015-08-14 1,617,326
   Van Wart Harold President and CEO, Director 2015-05-18 7,958 0
   Alta Embarcadero Biopharma Partners III Llc 10% Owner 2013-10-11 960,433 2013-10-11 88,169
   Versant Side Fund Ii, Lp 10% Owner 2013-10-11 1,020,127 2013-10-11 28,474
   Lange Louis G Director 2013-10-11 1,446 0
   Penhoet Edward Director 0 2013-10-11 1,048,602
   Boudes Pol F 0 0
   Aghazadeh Behzad 10% Owner 0 2020-08-03 10,300,000
   Martin Robert L. 0 0
   Rosemark Kirk 0 0
24 Records found